Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
63 participants
INTERVENTIONAL
2008-06-30
2010-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Test@Work Study: Evaluation of Attitudes and Uptake Within Employee Health Checks in the Construction Industry
NCT04292002
Identifying Risks of COVID-19 Outbreaks in Work Settings and the Implications for Control Measures
NCT05197673
Randomized Controlled Trial on Uptake of NHS Health Checks
NCT03524131
Computerized Risk Assessment in an Employee Population
NCT00153335
Diet and Activity Promotion Among Older Working Adults
NCT01233063
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
That H@W intervention in comparison to standard care:
* promotes work retention
* enables a quick and sustained return to work for those on short term sick leave (4 weeks or less)
* achieves sustained return to work for those on long term sick leave of 4 weeks or more. This could include a phased return to work.
* achieves positive outcomes which could mean leaving one job and starting another.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
workplace health advice
The intervention group will receive additional support from a H@W Workplace Health Advisor who will deliver an intervention aimed at sickness absence prevention or sustained return to work, depending on individual circumstances.
Health at Work workplace health advice and support
The intervention group will receive additional support from a H@W Workplace Health Advisor who will deliver an intervention aimed at sickness absence prevention or sustained return to work, depending on individual circumstances. The intervention will be standardized as far as possible to show types of activity undertaken with participants, their GP, line managers, human resources departments and trade union representatives.
GP sickness absence consultation
Routine general practitioner care for workplace sickness absence.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Health at Work workplace health advice and support
The intervention group will receive additional support from a H@W Workplace Health Advisor who will deliver an intervention aimed at sickness absence prevention or sustained return to work, depending on individual circumstances. The intervention will be standardized as far as possible to show types of activity undertaken with participants, their GP, line managers, human resources departments and trade union representatives.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Vulnerable adults and those considered by their GP to be unsuitable for the trial.
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Liverpool
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mark B Gabbay, MD
Role: PRINCIPAL_INVESTIGATOR
University of Liverpool
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Division of Primary Care, University of Liverpool.
Liverpool, Merseyside, United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
BER10457
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.